| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SECT-B.ST - | HOLD | 0 @ SEK 21.7558 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 21.7558. The average price that SECT-B.ST shares were previous bought at was SEK 28.5764. The current market price is -23.9% lower than average price they were purchased at. The value of the holding in SECT-B.ST has fallen by SEK 5,563 (USD $603) compared to the previous valuation of |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 136.3 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 136.3. The average price that IPN.PA shares were previous bought at was EUR 104.662. The current market price is 30.2% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 139,586 (USD $162,513) compared to the previous valuation of Ipsen SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 599.098 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 599.098. The average price that LONN.SW shares were previous bought at was CHF 604.613. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 75,090 (USD $93,744) compared to the previous valuation of |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 127 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 127. The average price that MRK.DE shares were previous bought at was EUR 116.341. The current market price is 9.2% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 98,198 (USD $114,327) compared to the previous valuation of Merck KGaA |
| NOVN.SW - | HOLD | 0 @ CHF 124.608 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 124.608. The average price that NOVN.SW shares were previous bought at was CHF 102.38. The current market price is 21.7% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 2,207,106 (USD $2,755,404) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 50.6242 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 50.6242. The average price that NOVO-B.CO shares were previous bought at was DKK 62.0089. The current market price is -18.4% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 933,527 (USD $145,472) compared to the previous valuation of Novo Nordisk A/S |
| NSIS-B.CO - | HOLD | 0 @ DKK 56.5063 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 56.5063. The average price that NSIS-B.CO shares were previous bought at was DKK 60.4828. The current market price is -6.6% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has increased by DKK 67,772 (USD $10,561) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 70.3 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 70.3. The average price that ORNBV.HE shares were previous bought at was EUR 60.3732. The current market price is 16.4% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 355,438 (USD $413,820) compared to the previous valuation of Orion Oyj however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 25.73 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 25.73. The average price that PHIA.AS shares were previous bought at was EUR 21.2058. The current market price is 21.3% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 30,498 (USD $35,507) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.38 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.38. The average price that REC.MI shares were previous bought at was EUR 53.1347. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 17,268 (USD $20,104) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 369.444 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 369.444. The average price that ROG.SW shares were previous bought at was CHF 286.083. The current market price is 29.1% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,106,137 (USD $1,380,928) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 82.55 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 82.55. The average price that SAN.PA shares were previous bought at was EUR 88.5053. The current market price is -6.7% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 1,011,562 (USD $1,177,714) compared to the previous valuation of Sanofi SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 65.7934 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 65.7934. The average price that SDZ.SW shares were previous bought at was CHF 45.334. The current market price is 45.1% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 424,148 (USD $529,516) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.22506 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.22506. The average price that HLN.L shares were previous bought at was GBP 4.55196. The current market price is -7.2% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 176,635 (USD $237,164) compared to the previous valuation of Haleon PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SFZN.SW - | HOLD | 0 @ CHF 92.1193 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 92.1193. The average price that SFZN.SW shares were previous bought at was CHF 104.924. The current market price is -12.2% lower than average price they were purchased at. The value of the holding in SFZN.SW has increased by CHF 56,055 (USD $69,980) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 47.05 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 47.05. The average price that SHL.DE shares were previous bought at was EUR 47.75. The current market price is -1.5% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 43,857 (USD $51,061) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.0162 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.0162. The average price that SN.L shares were previous bought at was GBP 12.8575. The current market price is 9.0% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 54,156 (USD $72,714) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 31.9047 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.9047. The average price that SOBI.ST shares were previous bought at was SEK 26.7916. The current market price is 19.1% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 58,283 (USD $6,320) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 238.243 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 238.243. The average price that SOON.SW shares were previous bought at was CHF 268.015. The current market price is -11.1% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 9,642 (USD $12,037) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 252.2 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 252.2. The average price that SRT3.DE shares were previous bought at was EUR 217.994. The current market price is 15.7% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 81,525 (USD $94,916) compared to the previous valuation of Sartorius AG |
| STMN.SW - | HOLD | 0 @ CHF 107.022 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 107.022. The average price that STMN.SW shares were previous bought at was CHF 112.761. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 20,166 (USD $25,176) compared to the previous valuation of |
| TECN.SW - | HOLD | 0 @ CHF 165.987 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 165.987. The average price that TECN.SW shares were previous bought at was CHF 175.966. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in TECN.SW has fallen by CHF 19,231 (USD $24,008) compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 232 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 232. The average price that TUB.BR shares were previous bought at was EUR 134.464. The current market price is 72.5% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 55,284 (USD $64,365) compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 259.6 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 259.6. The average price that UCB.BR shares were previous bought at was EUR 167.894. The current market price is 54.6% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 290,256 (USD $337,931) compared to the previous valuation of UCB SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 55.342 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 55.342. The average price that ZEAL.CO shares were previous bought at was DKK 59.1439. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 13,177 (USD $2,053) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 31.2378 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 31.2378. The average price that DEMANT.CO shares were previous bought at was DKK 35.1227. The current market price is -11.1% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 2,201 (USD $343) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 68.4346 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.4346. The average price that ALC.SW shares were previous bought at was CHF 77.0204. The current market price is -11.1% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 159,390 (USD $198,986) compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 30.6756 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 30.6756. The average price that ALK-B.CO shares were previous bought at was DKK 24.063. The current market price is 27.5% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 8,652 (USD $1,348) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 12.1792 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 12.1792. The average price that AMBU-B.CO shares were previous bought at was DKK 13.7187. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has increased by DKK 97 (USD $15) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.84 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.84. The average price that AMP.MI shares were previous bought at was EUR 19.8189. The current market price is -30.2% lower than average price they were purchased at. The value of the holding in AMP.MI has increased by EUR 9,919 (USD $11,548) compared to the previous valuation of Amplifon SpA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 690.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 690.8. The average price that ARGX.BR shares were previous bought at was EUR 525.504. The current market price is 31.5% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 165,459 (USD $192,636) compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 165.563 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 165.563. The average price that AZN.L shares were previous bought at was GBP 127.143. The current market price is 30.2% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 2,694,491 (USD $3,617,835) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| BAVA.CO - | HOLD | 0 @ DKK 26.9014 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 26.9014. The average price that BAVA.CO shares were previous bought at was DKK 23.0839. The current market price is 16.5% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 6,062 (USD $945) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 41.67 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 41.67. The average price that BAYN.DE shares were previous bought at was EUR 26.2448. The current market price is 58.8% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 1,160,863 (USD $1,351,538) compared to the previous valuation of Bayer AG however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 108.1 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 108.1. The average price that BIM.PA shares were previous bought at was EUR 118.427. The current market price is -8.7% lower than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 2,098 (USD $2,443) compared to the previous valuation of BioMerieux however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| CAMX.ST - | HOLD | 0 @ SEK 64.4355 | SEK 0 | The current share valuation price of CAMX.ST based on adjusted close was SEK 64.4355. The average price that CAMX.ST shares were previous bought at was SEK 56.2613. The current market price is 14.5% higher than average price they were purchased at. The value of the holding in CAMX.ST has increased by SEK 11,313 (USD $1,227) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 76.6623 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 76.6623. The average price that COLO-B.CO shares were previous bought at was DKK 85.2136. The current market price is -10.0% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 31,757 (USD $4,949) compared to the previous valuation of |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.71669 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.71669. The average price that CTEC.L shares were previous bought at was GBP 3.01533. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in CTEC.L has fallen by GBP 4,512 (USD $6,058) compared to the previous valuation of ConvaTec Group PLC |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 108 | EUR 0 | The current share valuation price of ABVX.PA based on adjusted close was EUR 108. The average price that ABVX.PA shares were previous bought at was EUR 100.227. The current market price is 7.8% higher than average price they were purchased at. The value of the holding in ABVX.PA has increased by EUR 105,692 (USD $123,052) compared to the previous valuation of Abivax SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 209.7 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 209.7. The average price that DIM.PA shares were previous bought at was EUR 199.575. The current market price is 5.1% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 59,890 (USD $69,727) compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 279.4 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 279.4. The average price that EL.PA shares were previous bought at was EUR 250.248. The current market price is 11.6% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 189,833 (USD $221,014) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 72 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 72. The average price that ERF.PA shares were previous bought at was EUR 58.4412. The current market price is 23.2% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 57,539 (USD $66,990) compared to the previous valuation of Eurofins Scientific SE |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 36.97 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 36.97. The average price that FME.DE shares were previous bought at was EUR 47.4075. The current market price is -22.0% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 215,838 (USD $251,290) compared to the previous valuation of Fresenius Medical Care AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 51.98 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 51.98. The average price that FRE.DE shares were previous bought at was EUR 42.8728. The current market price is 21.2% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 131,877 (USD $153,538) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 173.502 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 173.502. The average price that GALD.SW shares were previous bought at was CHF 128.821. The current market price is 34.7% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 201,560 (USD $251,632) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GETI-B.ST - | HOLD | 0 @ SEK 20.6156 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 20.6156. The average price that GETI-B.ST shares were previous bought at was SEK 17.466. The current market price is 18.0% higher than average price they were purchased at. The value of the holding in GETI-B.ST has fallen by SEK 6,634 (USD $719) compared to the previous valuation of |
| GMAB.CO - | HOLD | 0 @ DKK 301.269 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 301.269. The average price that GMAB.CO shares were previous bought at was DKK 192.304. The current market price is 56.7% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 392,257 (USD $61,126) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 11.675 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 11.675. The average price that GRF.MC shares were previous bought at was EUR 10.445. The current market price is 11.8% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 89,125 (USD $103,764) compared to the previous valuation of Grifols SA however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 21.7024 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 21.7024. The average price that GSK.L shares were previous bought at was GBP 17.2647. The current market price is 25.7% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 484,219 (USD $650,150) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 18.0843 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 18.0843. The average price that HIK.L shares were previous bought at was GBP 23.5355. The current market price is -23.2% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 24,387 (USD $32,744) compared to the previous valuation of however if the holding was sold on 2026-01-14 this would crystalise an overall loss. |